iShares Biotechnology ETF (IBB) Short Interest Ratio & Short Volume → The Gold Grab of the Century (From Colonial Metals) (Ad) Free IBB Stock Alerts $132.96 +2.31 (+1.77%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestSocial Media iShares Biotechnology ETF Short Interest DataCurrent Short Volume8,740,000 sharesPrevious Short Volume8,380,000 sharesChange Vs. Previous Month+4.30%Dollar Volume Sold Short$1.20 billionShort Interest Ratio / Days to Cover4.6Last Record DateJanuary 15, 2024Outstanding Shares54,950,000 sharesPercentage of Shares Shorted15.91%Today's Trading Volume1,804,184 sharesAverage Trading Volume1,700,513 sharesToday's Volume Vs. Average106% Short Selling iShares Biotechnology ETF ? Sign up to receive the latest short interest report for iShares Biotechnology ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIBB Short Interest Over TimeIBB Days to Cover Over TimeIBB Percentage of Float Shorted Over Time Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. iShares Biotechnology ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/20248,740,000 shares $1.20 billion +4.3%N/A4.6 $137.13 12/31/20238,380,000 shares $1.14 billion -14.1%N/A4.2 $135.85 12/15/20239,760,000 shares $1.29 billion -8.9%N/A4.7 $131.78 11/30/202310,710,000 shares $1.30 billion +5.6%N/A5.5 $120.93 11/15/202310,140,000 shares $1.20 billion -3.9%N/A5.2 $118.03 10/31/202310,550,000 shares $1.20 billion +6.5%N/A5.7 $113.68 Get the Latest News and Ratings for IBB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 10/15/20239,910,000 shares $1.21 billion -2.5%N/A6 $121.63 9/30/202310,160,000 shares $1.24 billion +7.7%N/A6.7 $122.29 9/15/20239,430,000 shares $1.19 billion -7.0%N/A6.6 $126.61 8/31/202310,140,000 shares $1.31 billion -0.4%N/A6.6 $128.71 8/15/202310,180,000 shares $1.30 billion +1.9%N/A6.6 $128.01 7/31/20239,990,000 shares $1.29 billion +2.7%N/A6.3 $129.31 7/15/20239,730,000 shares $1.25 billion -7.3%N/A6 $128.24 6/30/202310,500,000 shares $1.33 billion +0.4%N/A6.5 $126.96 6/15/202310,460,000 shares $1.38 billion +10.2%N/A6.7 $131.81 5/31/20239,490,000 shares $1.20 billion +1.3%N/A6 $126.28 5/15/20239,370,000 shares $1.23 billion -6.4%N/A6 $131.74 4/30/202310,010,000 shares $1.31 billion +2.5%N/A6.4 $130.51 4/15/20239,770,000 shares $1.29 billion -0.8%N/A6.3 $132.43 3/31/20239,850,000 shares $1.27 billion -6.5%N/A6.4 $129.16 3/15/202310,530,000 shares $1.33 billion +12.4%N/A6.7 $126.06 2/28/20239,370,000 shares $1.19 billion -7.0%N/A6.2 $127.18 2/15/202310,070,000 shares $1.35 billion +6.7%N/A6.4 $133.77 1/31/20239,440,000 shares $1.29 billion -4.4%N/A5.6 $136.55 1/15/20239,870,000 shares $1.34 billion -5.5%N/A5.6 $136.23 12/30/202210,440,000 shares $1.37 billion +4.7%N/A5.7 $131.29 12/15/20229,970,000 shares $1.34 billion -8.8%N/A5.2 $134.24 11/30/202210,930,000 shares $1.49 billion +5.0%N/A5.5 $136.53 11/15/202210,410,000 shares $1.41 billion +6.9%N/A5.3 $135.11 10/31/20229,740,000 shares $1.25 billion -15.4%N/A5.1 $128.59 10/15/202211,510,000 shares $1.38 billion No ChangeN/A6.2 $119.58 9/30/20229,180,000 shares $1.07 billion +16.8%N/A4.9 $116.96 9/15/20227,860,000 shares $975.03 million +12.8%N/A4.1 $124.05 8/31/20226,970,000 shares $846.58 million -19.6%N/A3.5 $121.46 8/15/20228,670,000 shares $1.17 billion +14.4%N/A4.3 $134.82 7/31/20227,580,000 shares $940.53 million -2.3%N/A3.2 $124.08 7/15/20227,760,000 shares $956.42 million -12.7%N/A3 $123.25 6/30/20228,890,000 shares $1.05 billion +1.1%N/A3.3 $117.63 6/15/20228,790,000 shares $955.12 million +12.7%N/A3.2 $108.66 5/31/20227,800,000 shares $910.03 million -6.0%N/A2.9 $116.67BUY ALERT: Tiny tech play partners with US government (Ad)The Federal Reserve is rolling out a powerful new financial technology across the entire U.S. banking system. It's forecasted to grow 24,290% in the near future... Meaning, your bank is nearly certain to adopt it (if it hasn't already).Get the full story here while you can. IBB Short Interest - Frequently Asked Questions What is iShares Biotechnology ETF's current short interest? Short interest is the volume of iShares Biotechnology ETF shares that have been sold short but have not yet been covered or closed out. As of January 15th, investors have sold 8,740,000 shares of IBB short. Learn More on iShares Biotechnology ETF's current short interest. What is a good short interest ratio for iShares Biotechnology ETF? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IBB shares currently have a short interest ratio of 5.0. Learn More on iShares Biotechnology ETF's short interest ratio. Which institutional investors are shorting iShares Biotechnology ETF? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of iShares Biotechnology ETF: Nomura Holdings Inc., Paloma Partners Management Co, UBS Group AG, and BNP Paribas Financial Markets. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is iShares Biotechnology ETF's short interest increasing or decreasing? iShares Biotechnology ETF saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 8,740,000 shares, an increase of 4.3% from the previous total of 8,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does iShares Biotechnology ETF's short interest compare to its competitors? Here is how the short interest of companies compare to iShares Biotechnology ETF: VanEck Pharmaceutical ETF (24.39%), VanEck Biotech ETF (0.09%), Invesco S&P SmallCap Health Care ETF (0.03%), ProShares Ultra Nasdaq Biotechnology (2.28%), Principal Healthcare Innovators ETF (0.32%), Invesco Nasdaq Biotechnology ETF (1.75%), First Trust Nasdaq Pharmaceuticals ETF (0.13%), JPMorgan Healthcare Leaders ETF (0.08%), and ProShares UltraShort Nasdaq Biotechnology (7.88%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.10 billion), General Motors ($3.90 billion), Charter Communications, Inc. ($3.31 billion), Occidental Petroleum Co. ($2.91 billion), Tractor Supply ($2.75 billion), Moderna, Inc. ($2.44 billion), Coinbase Global, Inc. ($2.10 billion), United Rentals, Inc. ($2.09 billion), Royal Caribbean Cruises Ltd. ($2.03 billion), and Rivian Automotive, Inc. ($1.89 billion). View all of the most shorted stocks. What does it mean to sell short iShares Biotechnology ETF stock? Short selling IBB is an investing strategy that aims to generate trading profit from iShares Biotechnology ETF as its price is falling. IBB shares are trading up $2.31 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against iShares Biotechnology ETF? A short squeeze for iShares Biotechnology ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IBB, which in turn drives the price of the stock up even further. How often is iShares Biotechnology ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IBB, twice per month. The most recent reporting period available is January, 15 2024. More Short Interest Resources from MarketBeat Related Companies: PPH Short Interest BBH Short Interest PSCH Short Interest BIB Short Interest BTEC Short Interest IBBQ Short Interest FTXH Short Interest JDOC Short Interest BIS Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IBB) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldCould Your Accounts Be Frozen?Allegiance GoldAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingJeff Bezos Just Humiliated Elon MuskInvestorPlaceForget Nvidia. This is the future of AIPorter & CompanyThe asset beating inflation by 4xColonial Metals